Chimeric clocks $4.17M R&D tax rebate from Canberra
Chimeric Therapeutics (ASX:CHM) has confirmed its receipt of a $4.17M tax rebate from Canberra for R&D activities.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TRY | Ann: Extension to Investec Loan Schedule Terms | 11:26 | 12 | 1.8K | |||
|
|||||||
TRY | the waiting game | 27/03/19 | 15 | 3.2K | |||
|
|||||||
TRY | Latest oustanding drill results | 22/03/19 | 18 | 8.3K | |||
|
|||||||
TRY | Ann: Extension of SPP CLosing Date | 21/03/19 | 127 | 97K | |||
|
|||||||
TRY | Ann: Outstanding Results from Ohio Ck Extend Strike Length | 19/03/19 | 5 | 30K | |||
|
|||||||
TRY | Ann: Change of Director's Interest Notice x 3 | 18/03/19 | 22 | 6.5K | |||
|
|||||||
TRY | Ann: Completion of SPP | 14/03/19 | 55 | 10K | |||
|
|||||||
TRY | Ann: Appendix 3B | 12/03/19 | 0 | 433 | |||
|
See All Discussions